Zentrum für Gastroenterologie Saar MVZ GmbH
Industry / private company
Location:
Saarbrücken,
Germany (DE)
Comparative real-world effectiveness of ustekinumab versus anti-TNF in Crohn's disease: 12-month maintenance phase results from the prospective, observational RUN-CD study using propensity score adjustment (2025)
Bokemeyer B, Plachta-Danielzik S, Gilman E, Di Giuseppe R, Deppe H, Mohl W, Teich N, et al.
Journal article
Real-World Effectiveness of Vedolizumab vs Anti-TNF in Biologic-naïve Crohn's Disease Patients: A 2-year Propensity-score-adjusted Analysis from the VEDOIBD-Study. (2024)
Bokemeyer B, Plachta-Danielzik S, Di Giuseppe R, Efken P, Mohl W, Hoffstadt M, Krause T, et al.
Journal article
Thumb sucking or nail biting in childhood and adolescence is associated with an increased risk of Crohn’s disease: results from a large case–control study (2020)
Teich N, Mohl W, Primas C, Novacek G, Gauss A, Walldorf J, Felten G, et al.
Journal article